Next 10 |
home / stock / nriff / nriff news
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea Canada NewsWire - First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - ...
Nuvo Pharmaceuticals' ([[NRIFF]] -0.6%), d/b/a Miravo Healthcare, wholly owned subsidiary entered into an exclusive license and supply agreement with Espoo, Finland headquartered Orion for the exclusive right to package, distribute, market and sell Suvexx in select E...
Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets PR Newswire - First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments -...
Nuvo Pharmaceuticals (NRIFF) announced that effective immediately it will begin business as d/b/a Miravo Healthcare; company is not changing its legal name or those of its wholly owned subsidiaries.As part of the corporate rebranding, effective Jan. 4, 2021, the company will trade u...
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™ - Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON , Dec. 18, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX:NRI) (OTCQX:NRIFF) d/b/...
Nuvo Pharmaceuticals Inc. (NRIFF) Q3 2020 Results Earnings Conference Call November 16, 2020, 08:30 AM ET Company Participants Jesse Ledger - President & CEO Kelly Demerino - Interim CFO Tina Loucaides - VP, Secretary & General Counsel. Conference Call Participants David Martin - Bloo...
The following slide deck was published by Nuvo Pharmaceuticals Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Nuvo Pharmaceuticals Inc. 2020 Q3 - Results - Earnings Call Presentation
Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results Canada NewsWire MISSISSAUGA, ON, Nov. 16, 2020 - Q3 2020 Adjusted Total Revenue - $16.7 million - - Q3 2020 Adjusted EBITDA - $6.6 million - - Blexten Canadian...
Nuvo Pharmaceuticals™ Announces Third Quarter 2020 Results Release Date and Conference Call Details PR Newswire MISSISSAUGA, ON, Nov. 2, 2020 MISSISSAUGA, ON, Nov. 2, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI) (OTCQ...
Growth Company Investor Presentations Now Available for On-Demand Viewing Canada NewsWire NEW YORK, Oct. 12, 2020 Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YO...
News, Short Squeeze, Breakout and More Instantly...
Nuvo Research Inc Company Name:
NRIFF Stock Symbol:
OTCMKTS Market:
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea Canada NewsWire - First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - ...
Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets PR Newswire - First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments -...
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™ - Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON , Dec. 18, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX:NRI) (OTCQX:NRIFF) d/b/...